共 50 条
- [31] Quantification of circulating TCR-engineered T cells targeting a human endogenous retrovirus post-adoptive transfer using nanoplate digital PCR[J]. MOLECULAR THERAPY METHODS & CLINICAL DEVELOPMENT, 2024, 32 (03)Barisic, Stefan论文数: 0 引用数: 0 h-index: 0机构: NHLBI, Lab Transplantat Immunotherapy, Cellular & Mol Therapeut Branch, NIH, Bethesda, MD 20892 USA NHLBI, Lab Transplantat Immunotherapy, Cellular & Mol Therapeut Branch, NIH, Bethesda, MD 20892 USACherkasova, Elena论文数: 0 引用数: 0 h-index: 0机构: NHLBI, Lab Transplantat Immunotherapy, Cellular & Mol Therapeut Branch, NIH, Bethesda, MD 20892 USA NHLBI, Lab Transplantat Immunotherapy, Cellular & Mol Therapeut Branch, NIH, Bethesda, MD 20892 USANadal, Rosa论文数: 0 引用数: 0 h-index: 0机构: NHLBI, Lab Transplantat Immunotherapy, Cellular & Mol Therapeut Branch, NIH, Bethesda, MD 20892 USA NHLBI, Lab Transplantat Immunotherapy, Cellular & Mol Therapeut Branch, NIH, Bethesda, MD 20892 USATian, Xin论文数: 0 引用数: 0 h-index: 0机构: NHLBI, Off Biostat Res, NIH, Bethesda, MD 20892 USA NHLBI, Lab Transplantat Immunotherapy, Cellular & Mol Therapeut Branch, NIH, Bethesda, MD 20892 USAChen, Long论文数: 0 引用数: 0 h-index: 0机构: NHLBI, Lab Transplantat Immunotherapy, Cellular & Mol Therapeut Branch, NIH, Bethesda, MD 20892 USA NHLBI, Lab Transplantat Immunotherapy, Cellular & Mol Therapeut Branch, NIH, Bethesda, MD 20892 USAParrizzi, Angelina论文数: 0 引用数: 0 h-index: 0机构: NHLBI, Lab Transplantat Immunotherapy, Cellular & Mol Therapeut Branch, NIH, Bethesda, MD 20892 USA NHLBI, Lab Transplantat Immunotherapy, Cellular & Mol Therapeut Branch, NIH, Bethesda, MD 20892 USAReger, Robert N.论文数: 0 引用数: 0 h-index: 0机构: NHLBI, Lab Transplantat Immunotherapy, Cellular & Mol Therapeut Branch, NIH, Bethesda, MD 20892 USA NHLBI, Lab Transplantat Immunotherapy, Cellular & Mol Therapeut Branch, NIH, Bethesda, MD 20892 USAScurti, Gina M.论文数: 0 引用数: 0 h-index: 0机构: Loyola Univ Chicago, Dept Surg, Maywood, IL 60153 USA NHLBI, Lab Transplantat Immunotherapy, Cellular & Mol Therapeut Branch, NIH, Bethesda, MD 20892 USANishimura, Michael I.论文数: 0 引用数: 0 h-index: 0机构: Loyola Univ Chicago, Dept Surg, Maywood, IL 60153 USA NHLBI, Lab Transplantat Immunotherapy, Cellular & Mol Therapeut Branch, NIH, Bethesda, MD 20892 USAChilds, Richard W.论文数: 0 引用数: 0 h-index: 0机构: NHLBI, Lab Transplantat Immunotherapy, Cellular & Mol Therapeut Branch, NIH, Bethesda, MD 20892 USA NHLBI, Lab Transplantat Immunotherapy, Cellular & Mol Therapeut Branch, NIH, Bethesda, MD 20892 USA
- [32] Lentiviral TCR-engineered Tregs Demonstrate Effective Suppression of T Cell Responses[J]. CLINICAL IMMUNOLOGY, 2010, 135 : S30 - S30Bruskol, Todd论文数: 0 引用数: 0 h-index: 0机构: Univ Calif San Francisco, San Francisco, CA 94143 USA Univ Calif San Francisco, San Francisco, CA 94143 USAKoya, Richard论文数: 0 引用数: 0 h-index: 0机构: Univ Calif Los Angeles, Los Angeles, CA USA Univ Calif San Francisco, San Francisco, CA 94143 USAZhu, Shirley论文数: 0 引用数: 0 h-index: 0机构: Univ Calif San Francisco, San Francisco, CA 94143 USA Univ Calif San Francisco, San Francisco, CA 94143 USALee, Michael论文数: 0 引用数: 0 h-index: 0机构: Univ Calif San Francisco, San Francisco, CA 94143 USA Univ Calif San Francisco, San Francisco, CA 94143 USAPutnam, Amy论文数: 0 引用数: 0 h-index: 0机构: Univ Calif San Francisco, San Francisco, CA 94143 USA Univ Calif San Francisco, San Francisco, CA 94143 USAMcClymont, Stephanie论文数: 0 引用数: 0 h-index: 0机构: Univ Calif San Francisco, San Francisco, CA 94143 USA Univ Calif San Francisco, San Francisco, CA 94143 USANishimura, Michael论文数: 0 引用数: 0 h-index: 0机构: Med Univ S Carolina, Charleston, SC 29425 USA Univ Calif San Francisco, San Francisco, CA 94143 USAXia, Ning论文数: 0 引用数: 0 h-index: 0机构: Univ Calif San Francisco, San Francisco, CA 94143 USA Univ Calif San Francisco, San Francisco, CA 94143 USABluestone, Jeffrey论文数: 0 引用数: 0 h-index: 0机构: Univ Calif San Francisco, San Francisco, CA 94143 USA Univ Calif San Francisco, San Francisco, CA 94143 USA
- [33] TCR-engineered T cell therapy in solid tumors: State of the art and perspectives[J]. SCIENCE ADVANCES, 2023, 9 (07)Baulu, Estelle论文数: 0 引用数: 0 h-index: 0机构: Ctr Rech Cancerol Lyon, Lyon, France ErVaccine Technol, Lyon, France Ctr Rech Cancerol Lyon, Lyon, FranceGardett, Celia论文数: 0 引用数: 0 h-index: 0机构: Ctr Rech Cancerol Lyon, Lyon, France Ctr Rech Cancerol Lyon, Lyon, FranceChuvin, Nicolas论文数: 0 引用数: 0 h-index: 0机构: ErVaccine Technol, Lyon, France Ctr Rech Cancerol Lyon, Lyon, FranceDepil, Stephane论文数: 0 引用数: 0 h-index: 0机构: Ctr Rech Cancerol Lyon, Lyon, France ErVaccine Technol, Lyon, France Ctr Leon Berard, Lyon, France Univ Claude Bernard Lyon 1, Lyon, France Ctr Rech Cancerol Lyon, Lyon, France
- [34] Transcriptional signatures in human melanoma epitope MART-127-35 specific TCR-engineered T cells[J]. CANCER RESEARCH, 2014, 74 (19)Singh, Prashant论文数: 0 引用数: 0 h-index: 0机构: Univ Connecticut, Ctr Hlth, Farmington, CT USA Univ Connecticut, Ctr Hlth, Farmington, CT USAChakraborty, Nitya G.论文数: 0 引用数: 0 h-index: 0机构: Univ Connecticut, Ctr Hlth, Farmington, CT USA Univ Connecticut, Ctr Hlth, Farmington, CT USAFarooq, Umar论文数: 0 引用数: 0 h-index: 0机构: Univ Connecticut, Ctr Hlth, Farmington, CT USA Univ Connecticut, Ctr Hlth, Farmington, CT USAHegde, Upendra P.论文数: 0 引用数: 0 h-index: 0机构: Univ Connecticut, Ctr Hlth, Farmington, CT USA Univ Connecticut, Ctr Hlth, Farmington, CT USAEverson, Richard论文数: 0 引用数: 0 h-index: 0机构: Univ Connecticut, Ctr Hlth, Farmington, CT USA Univ Connecticut, Ctr Hlth, Farmington, CT USADorsky, David I.论文数: 0 引用数: 0 h-index: 0机构: Univ Connecticut, Ctr Hlth, Farmington, CT USA Univ Connecticut, Ctr Hlth, Farmington, CT USAMukherji, Bijay论文数: 0 引用数: 0 h-index: 0机构: Univ Connecticut, Ctr Hlth, Farmington, CT USA Univ Connecticut, Ctr Hlth, Farmington, CT USA
- [35] Enhancing Efficacy of TCR-engineered CD4+ T Cells Via Coexpression of CD8α[J]. JOURNAL OF IMMUNOTHERAPY, 2023, 46 (04) : 132 - 144Anderson, Victoria E.论文数: 0 引用数: 0 h-index: 0机构: Adaptimmune, Abingdon, Oxon, England Adaptimmune, 60 Jubilee Ave, Abingdon OX14 4RX, Oxon, England Adaptimmune, Abingdon, Oxon, EnglandBrilha, Sara S.论文数: 0 引用数: 0 h-index: 0机构: Adaptimmune, Abingdon, Oxon, England Adaptimmune, Abingdon, Oxon, EnglandWeber, Anika M.论文数: 0 引用数: 0 h-index: 0机构: Adaptimmune, Abingdon, Oxon, England Adaptimmune, Abingdon, Oxon, EnglandPachnio, Annette论文数: 0 引用数: 0 h-index: 0机构: Adaptimmune, Abingdon, Oxon, England Adaptimmune, Abingdon, Oxon, EnglandWiedermann, Guy E.论文数: 0 引用数: 0 h-index: 0机构: Adaptimmune, Abingdon, Oxon, England Adaptimmune, Abingdon, Oxon, EnglandDauleh, Sumaya论文数: 0 引用数: 0 h-index: 0机构: Adaptimmune, Abingdon, Oxon, England Adaptimmune, Abingdon, Oxon, EnglandAhmed, Tina论文数: 0 引用数: 0 h-index: 0机构: Adaptimmune, Abingdon, Oxon, England Adaptimmune, Abingdon, Oxon, EnglandPope, George R.论文数: 0 引用数: 0 h-index: 0机构: Adaptimmune, Abingdon, Oxon, England Adaptimmune, Abingdon, Oxon, EnglandQuinn, Laura L.论文数: 0 引用数: 0 h-index: 0机构: Adaptimmune, Abingdon, Oxon, England Adaptimmune, Abingdon, Oxon, EnglandDocta, Roslin Y.论文数: 0 引用数: 0 h-index: 0机构: Adaptimmune, Abingdon, Oxon, England Adaptimmune, Abingdon, Oxon, EnglandQuattrini, Adriano论文数: 0 引用数: 0 h-index: 0机构: Adaptimmune, Abingdon, Oxon, England Adaptimmune, Abingdon, Oxon, EnglandMasters, Siobhan论文数: 0 引用数: 0 h-index: 0机构: Adaptimmune, Abingdon, Oxon, England Adaptimmune, Abingdon, Oxon, EnglandCartwright, Neil论文数: 0 引用数: 0 h-index: 0机构: Adaptimmune, Abingdon, Oxon, England Adaptimmune, Abingdon, Oxon, EnglandViswanathan, Preetha论文数: 0 引用数: 0 h-index: 0机构: Adaptimmune, Abingdon, Oxon, England Adaptimmune, Abingdon, Oxon, EnglandMelchiori, Luca论文数: 0 引用数: 0 h-index: 0机构: Adaptimmune, Abingdon, Oxon, England Adaptimmune, Abingdon, Oxon, EnglandRice, Louise V.论文数: 0 引用数: 0 h-index: 0机构: Adaptimmune, Abingdon, Oxon, England Adaptimmune, Abingdon, Oxon, EnglandSevko, Alexandra论文数: 0 引用数: 0 h-index: 0机构: Adaptimmune, Abingdon, Oxon, England Adaptimmune, Abingdon, Oxon, EnglandGueguen, Claire论文数: 0 引用数: 0 h-index: 0机构: Adaptimmune, Abingdon, Oxon, England Adaptimmune, Abingdon, Oxon, EnglandSaini, Manoj论文数: 0 引用数: 0 h-index: 0机构: Adaptimmune, Abingdon, Oxon, England Adaptimmune, Abingdon, Oxon, EnglandTavano, Barbara论文数: 0 引用数: 0 h-index: 0机构: Adaptimmune, Abingdon, Oxon, England Adaptimmune, Abingdon, Oxon, EnglandAbbott, Rachel J. M.论文数: 0 引用数: 0 h-index: 0机构: Adaptimmune, Abingdon, Oxon, England Adaptimmune, Abingdon, Oxon, EnglandSilk, Jonathan D.论文数: 0 引用数: 0 h-index: 0机构: Adaptimmune, Abingdon, Oxon, England Adaptimmune, Abingdon, Oxon, EnglandLaugel, Bruno论文数: 0 引用数: 0 h-index: 0机构: Adaptimmune, Abingdon, Oxon, England Adaptimmune, Abingdon, Oxon, EnglandSanderson, Joseph P.论文数: 0 引用数: 0 h-index: 0机构: Adaptimmune, Abingdon, Oxon, England Adaptimmune, Abingdon, Oxon, EnglandGerry, Andrew B.论文数: 0 引用数: 0 h-index: 0机构: Adaptimmune, Abingdon, Oxon, England Adaptimmune, Abingdon, Oxon, England
- [36] A 3D microfluidic model for preclinical evaluation of TCR-engineered T cells against solid tumors[J]. JCI INSIGHT, 2017, 2 (12):Pavesi, Andrea论文数: 0 引用数: 0 h-index: 0机构: Agcy Sci Technol & Res, Inst Mol & Cell Biol, 61 Biopolis Dr,03-06 Proteos Bldg, Singapore 138673, Singapore Singapore MIT Alliance Res & Technol, BioSyst & Micromech, Singapore, Singapore Agcy Sci Technol & Res, Inst Mol & Cell Biol, 61 Biopolis Dr,03-06 Proteos Bldg, Singapore 138673, SingaporeTan, Anthony T.论文数: 0 引用数: 0 h-index: 0机构: Duke NUS Grad Med Sch, Emerging Infect Dis Program, Singapore, Singapore Agcy Sci Technol & Res, Inst Mol & Cell Biol, 61 Biopolis Dr,03-06 Proteos Bldg, Singapore 138673, SingaporeKoh, Sarene论文数: 0 引用数: 0 h-index: 0机构: Agcy Sci Technol & Res, Singapore Inst Clin Sci, Singapore, Singapore Agcy Sci Technol & Res, Inst Mol & Cell Biol, 61 Biopolis Dr,03-06 Proteos Bldg, Singapore 138673, SingaporeChia, Adeline论文数: 0 引用数: 0 h-index: 0机构: Duke NUS Grad Med Sch, Emerging Infect Dis Program, Singapore, Singapore Agcy Sci Technol & Res, Inst Mol & Cell Biol, 61 Biopolis Dr,03-06 Proteos Bldg, Singapore 138673, SingaporeColombo, Marta论文数: 0 引用数: 0 h-index: 0机构: Politecn Milan, Dept Chem Mat & Chem Engn Giulio Natta, Milan, Italy Agcy Sci Technol & Res, Inst Mol & Cell Biol, 61 Biopolis Dr,03-06 Proteos Bldg, Singapore 138673, SingaporeAntonecchia, Emanuele论文数: 0 引用数: 0 h-index: 0机构: Politecn Milan, Dept Chem Mat & Chem Engn Giulio Natta, Milan, Italy Agcy Sci Technol & Res, Inst Mol & Cell Biol, 61 Biopolis Dr,03-06 Proteos Bldg, Singapore 138673, SingaporeMiccolis, Carlo论文数: 0 引用数: 0 h-index: 0机构: Politecn Milan, Dept Chem Mat & Chem Engn Giulio Natta, Milan, Italy Agcy Sci Technol & Res, Inst Mol & Cell Biol, 61 Biopolis Dr,03-06 Proteos Bldg, Singapore 138673, SingaporeCeccarello, Erica论文数: 0 引用数: 0 h-index: 0机构: Duke NUS Grad Med Sch, Emerging Infect Dis Program, Singapore, Singapore Agcy Sci Technol & Res, Inst Mol & Cell Biol, 61 Biopolis Dr,03-06 Proteos Bldg, Singapore 138673, SingaporeAdriani, Giulia论文数: 0 引用数: 0 h-index: 0机构: Singapore MIT Alliance Res & Technol, BioSyst & Micromech, Singapore, Singapore Agcy Sci Technol & Res, Inst Mol & Cell Biol, 61 Biopolis Dr,03-06 Proteos Bldg, Singapore 138673, SingaporeRaimondi, Manuela T.论文数: 0 引用数: 0 h-index: 0机构: Politecn Milan, Dept Chem Mat & Chem Engn Giulio Natta, Milan, Italy Agcy Sci Technol & Res, Inst Mol & Cell Biol, 61 Biopolis Dr,03-06 Proteos Bldg, Singapore 138673, SingaporeKamm, Roger D.论文数: 0 引用数: 0 h-index: 0机构: Singapore MIT Alliance Res & Technol, BioSyst & Micromech, Singapore, Singapore MIT, Dept Biol Engn, MechanoBiol Lab, 77 Massachusetts Ave, Cambridge, MA 02139 USA Agcy Sci Technol & Res, Inst Mol & Cell Biol, 61 Biopolis Dr,03-06 Proteos Bldg, Singapore 138673, SingaporeBertoletti, Antonio论文数: 0 引用数: 0 h-index: 0机构: Duke NUS Grad Med Sch, Emerging Infect Dis Program, Singapore, Singapore Agcy Sci Technol & Res, Singapore Inst Clin Sci, Singapore, Singapore Agcy Sci Technol & Res, Inst Mol & Cell Biol, 61 Biopolis Dr,03-06 Proteos Bldg, Singapore 138673, Singapore
- [37] Engineered T cells for pancreatic cancer treatment[J]. HPB, 2011, 13 (09) : 643 - 650Katari, Usha L.论文数: 0 引用数: 0 h-index: 0机构: Texas Childrens Hosp, Ctr Cell & Gene Therapy, Baylor Coll Med, Houston, TX 77030 USA Methodist Hosp, Houston, TX 77030 USA Texas Childrens Hosp, Ctr Cell & Gene Therapy, Baylor Coll Med, Houston, TX 77030 USAKeirnan, Jacqueline M.论文数: 0 引用数: 0 h-index: 0机构: Texas Childrens Hosp, Ctr Cell & Gene Therapy, Baylor Coll Med, Houston, TX 77030 USA Methodist Hosp, Houston, TX 77030 USA Texas Childrens Hosp, Ctr Cell & Gene Therapy, Baylor Coll Med, Houston, TX 77030 USAWorth, Anna C.论文数: 0 引用数: 0 h-index: 0机构: Texas Childrens Hosp, Ctr Cell & Gene Therapy, Baylor Coll Med, Houston, TX 77030 USA Methodist Hosp, Houston, TX 77030 USA Texas Childrens Hosp, Ctr Cell & Gene Therapy, Baylor Coll Med, Houston, TX 77030 USAHodges, Sally E.论文数: 0 引用数: 0 h-index: 0机构: Baylor Coll Med, Elkins Pancreas Ctr, Houston, TX 77030 USA Texas Childrens Hosp, Ctr Cell & Gene Therapy, Baylor Coll Med, Houston, TX 77030 USALeen, Ann M.论文数: 0 引用数: 0 h-index: 0机构: Texas Childrens Hosp, Ctr Cell & Gene Therapy, Baylor Coll Med, Houston, TX 77030 USA Methodist Hosp, Houston, TX 77030 USA Texas Childrens Hosp, Ctr Cell & Gene Therapy, Baylor Coll Med, Houston, TX 77030 USAFisher, William E.论文数: 0 引用数: 0 h-index: 0机构: Baylor Coll Med, Elkins Pancreas Ctr, Houston, TX 77030 USA Texas Childrens Hosp, Ctr Cell & Gene Therapy, Baylor Coll Med, Houston, TX 77030 USAVera, Juan F.论文数: 0 引用数: 0 h-index: 0机构: Texas Childrens Hosp, Ctr Cell & Gene Therapy, Baylor Coll Med, Houston, TX 77030 USA Methodist Hosp, Houston, TX 77030 USA Texas Childrens Hosp, Ctr Cell & Gene Therapy, Baylor Coll Med, Houston, TX 77030 USA
- [38] Neoantigen-targeted TCR-engineered T cell immunotherapy: current advances and challenges[J]. BIOMARKER RESEARCH, 2023, 11 (01)Pang, Zhi论文数: 0 引用数: 0 h-index: 0机构: Fudan Univ, Zhongshan Hosp, Liver Canc Inst, Key Lab Carcinogenesis & Canc Invas,Minist Educ, Shanghai 200032, Peoples R China Fudan Univ, Zhongshan Hosp, Clin Ctr Biotherapy, Shanghai 200032, Peoples R China Fudan Univ, Zhongshan Hosp, Liver Canc Inst, Key Lab Carcinogenesis & Canc Invas,Minist Educ, Shanghai 200032, Peoples R ChinaLu, Man-man论文数: 0 引用数: 0 h-index: 0机构: Shanghai Inst Biomed & Pharmaceut Technol, Shanghai MOST Key Lab Hlth & Dis Genom, Shanghai 200237, Peoples R China Fudan Univ, Zhongshan Hosp, Liver Canc Inst, Key Lab Carcinogenesis & Canc Invas,Minist Educ, Shanghai 200032, Peoples R ChinaZhang, Yu论文数: 0 引用数: 0 h-index: 0机构: Shanghai Inst Biomed & Pharmaceut Technol, Shanghai MOST Key Lab Hlth & Dis Genom, Shanghai 200237, Peoples R China Fudan Univ, Zhongshan Hosp, Liver Canc Inst, Key Lab Carcinogenesis & Canc Invas,Minist Educ, Shanghai 200032, Peoples R ChinaGao, Yuan论文数: 0 引用数: 0 h-index: 0机构: Shanghai Inst Biomed & Pharmaceut Technol, Shanghai MOST Key Lab Hlth & Dis Genom, Shanghai 200237, Peoples R China Fudan Univ, Zhongshan Hosp, Liver Canc Inst, Key Lab Carcinogenesis & Canc Invas,Minist Educ, Shanghai 200032, Peoples R ChinaBai, Jin-jin论文数: 0 引用数: 0 h-index: 0机构: Fudan Univ, Zhongshan Hosp, Liver Canc Inst, Key Lab Carcinogenesis & Canc Invas,Minist Educ, Shanghai 200032, Peoples R China Fudan Univ, Zhongshan Hosp, Clin Ctr Biotherapy, Shanghai 200032, Peoples R China Fudan Univ, Zhongshan Hosp, Liver Canc Inst, Key Lab Carcinogenesis & Canc Invas,Minist Educ, Shanghai 200032, Peoples R ChinaGu, Jian-ying论文数: 0 引用数: 0 h-index: 0机构: Fudan Univ, Zhongshan Hosp, Clin Ctr Biotherapy, Shanghai 200032, Peoples R China Fudan Univ, Zhongshan Hosp, Liver Canc Inst, Key Lab Carcinogenesis & Canc Invas,Minist Educ, Shanghai 200032, Peoples R ChinaXie, Lu论文数: 0 引用数: 0 h-index: 0机构: Shanghai Inst Biomed & Pharmaceut Technol, Shanghai MOST Key Lab Hlth & Dis Genom, Shanghai 200237, Peoples R China Fudan Univ, Zhongshan Hosp, Liver Canc Inst, Key Lab Carcinogenesis & Canc Invas,Minist Educ, Shanghai 200032, Peoples R ChinaWu, Wei-zhong论文数: 0 引用数: 0 h-index: 0机构: Fudan Univ, Zhongshan Hosp, Liver Canc Inst, Key Lab Carcinogenesis & Canc Invas,Minist Educ, Shanghai 200032, Peoples R China Fudan Univ, Zhongshan Hosp, Clin Ctr Biotherapy, Shanghai 200032, Peoples R China Fudan Univ, Zhongshan Hosp, Liver Canc Inst, Key Lab Carcinogenesis & Canc Invas,Minist Educ, Shanghai 200032, Peoples R China
- [39] Neoantigen-targeted TCR-engineered T cell immunotherapy: current advances and challenges[J]. Biomarker Research, 11Zhi Pang论文数: 0 引用数: 0 h-index: 0机构: Zhongshan Hospital,Liver Cancer Institute, Key Laboratory of Carcinogenesis and Cancer Invasion, Ministry of EducationMan-man Lu论文数: 0 引用数: 0 h-index: 0机构: Zhongshan Hospital,Liver Cancer Institute, Key Laboratory of Carcinogenesis and Cancer Invasion, Ministry of EducationYu Zhang论文数: 0 引用数: 0 h-index: 0机构: Zhongshan Hospital,Liver Cancer Institute, Key Laboratory of Carcinogenesis and Cancer Invasion, Ministry of EducationYuan Gao论文数: 0 引用数: 0 h-index: 0机构: Zhongshan Hospital,Liver Cancer Institute, Key Laboratory of Carcinogenesis and Cancer Invasion, Ministry of EducationJin-jin Bai论文数: 0 引用数: 0 h-index: 0机构: Zhongshan Hospital,Liver Cancer Institute, Key Laboratory of Carcinogenesis and Cancer Invasion, Ministry of EducationJian-ying Gu论文数: 0 引用数: 0 h-index: 0机构: Zhongshan Hospital,Liver Cancer Institute, Key Laboratory of Carcinogenesis and Cancer Invasion, Ministry of EducationLu Xie论文数: 0 引用数: 0 h-index: 0机构: Zhongshan Hospital,Liver Cancer Institute, Key Laboratory of Carcinogenesis and Cancer Invasion, Ministry of EducationWei-zhong Wu论文数: 0 引用数: 0 h-index: 0机构: Zhongshan Hospital,Liver Cancer Institute, Key Laboratory of Carcinogenesis and Cancer Invasion, Ministry of Education
- [40] AFNT-111: A novel TCR-engineered T cell therapy targeting the oncogenic driver KRAS G12V[J]. MOLECULAR CANCER RESEARCH, 2023, 21 (05)Hoffmann, Michele论文数: 0 引用数: 0 h-index: 0机构: Affini T Therapeut, Watertown, MA USA Affini T Therapeut, Watertown, MA USAHe, Xingyue论文数: 0 引用数: 0 h-index: 0机构: Affini T Therapeut, Watertown, MA USA Affini T Therapeut, Watertown, MA USABlack, Cheryl论文数: 0 引用数: 0 h-index: 0机构: Affini T Therapeut, Seattle, WA USA Affini T Therapeut, Watertown, MA USAFrancis, Joshua论文数: 0 引用数: 0 h-index: 0机构: Affini T Therapeut, Watertown, MA USA Affini T Therapeut, Watertown, MA USAParsons, James论文数: 0 引用数: 0 h-index: 0机构: Affini T Therapeut, Seattle, WA USA Affini T Therapeut, Watertown, MA USARoy, Christian论文数: 0 引用数: 0 h-index: 0机构: Affini T Therapeut, Watertown, MA USA Affini T Therapeut, Watertown, MA USALiang, Jinsheng论文数: 0 引用数: 0 h-index: 0机构: Affini T Therapeut, Watertown, MA USA Affini T Therapeut, Watertown, MA USAQu, Hongjing论文数: 0 引用数: 0 h-index: 0机构: Affini T Therapeut, Watertown, MA USA Affini T Therapeut, Watertown, MA USACampbell, Martin论文数: 0 引用数: 0 h-index: 0机构: Affini T Therapeut, Seattle, WA USA Affini T Therapeut, Watertown, MA USASewastianik, Tomasz论文数: 0 引用数: 0 h-index: 0机构: Affini T Therapeut, Watertown, MA USA Affini T Therapeut, Watertown, MA USAWebb, Jessica论文数: 0 引用数: 0 h-index: 0机构: Fred Hutchinson Canc Res Ctr, Seattle, WA USA Affini T Therapeut, Watertown, MA USAChapuis, Aude论文数: 0 引用数: 0 h-index: 0机构: Fred Hutchinson Canc Res Ctr, Seattle, WA USA Affini T Therapeut, Watertown, MA USASchmitt, Thomas论文数: 0 引用数: 0 h-index: 0机构: Fred Hutchinson Canc Res Ctr, Seattle, WA USA Affini T Therapeut, Watertown, MA USAGreenberg, Philip论文数: 0 引用数: 0 h-index: 0机构: Fred Hutchinson Canc Res Ctr, Seattle, WA USA Affini T Therapeut, Watertown, MA USAHallet, Damien论文数: 0 引用数: 0 h-index: 0机构: Affini T Therapeut, Watertown, MA USA Affini T Therapeut, Watertown, MA USAVallaster, Markus论文数: 0 引用数: 0 h-index: 0机构: Affini T Therapeut, Watertown, MA USA Affini T Therapeut, Watertown, MA USAPierog, Piotr论文数: 0 引用数: 0 h-index: 0机构: Affini T Therapeut, Watertown, MA USA Affini T Therapeut, Watertown, MA USAShapiro, Gary论文数: 0 引用数: 0 h-index: 0机构: Affini T Therapeut, Watertown, MA USA Affini T Therapeut, Watertown, MA USALam, Hubert论文数: 0 引用数: 0 h-index: 0机构: Affini T Therapeut, Watertown, MA USA Affini T Therapeut, Watertown, MA USAVincent, Loic论文数: 0 引用数: 0 h-index: 0机构: Affini T Therapeut, Watertown, MA USA Affini T Therapeut, Watertown, MA USA